Class IITerminated

Voriconazole Tablets recall

FDA recall D-0307-2025 · initiated Mar 24, 2025

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.

Details

Product: Voriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered doses (30 Unit Dose per carton), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC 60687-294-21, Unit Dose NDC 60687-294-11.
Recalling company: Amerisource Health Services LLC
Classification: Class II
Status: Terminated
Type: Voluntary: Firm initiated
Distribution: USA nationwide.
Initiated: Mar 24, 2025
FDA report date: Apr 9, 2025

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0307-2025 ↗

← All drug recalls